Expression of cyclooxygenase and lipoxygenase enzymes in sinonasal mucosa of patients with cystic fibrosis

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 8, 2008, Pages 825-831

  Owens, Jonathan M ^a,c   Shroyer, Kenneth R ^b   Kingdom, Todd T ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE;

ADOLESCENT; ADULT; ARTICLE; CELL NUCLEUS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE MUCOSA; PROTEIN EXPRESSION; RHINOSINUSITIS; STATISTICAL SIGNIFICANCE; SUBMUCOSA;

ADOLESCENT; ADULT; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONATE 5-LIPOXYGENASE; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYSTIC FIBROSIS; FEMALE; HUMANS; LIPOXYGENASE; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REFERENCE VALUES; RHINITIS; SINUSITIS;

EID: 49949084540     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.134.8.825     Document Type: Article

References (32)

1. Oppenheimer EH, Rosenstein BJ. Differential pathology of nasal polyps in cystic fibrosis and atopy. Lab Invest. 1979;40(4):445-449.
2. Pujols L, Mullol J, Alobid I, Roca-Ferrer J, Xaubet A, Picado C. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. J Allergy Clin Immunol. 2004;114(4):814-819.
3. Owens JM, Shroyer KR, Kingdom TT. Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin-sensitive and aspirin-tolerant patients. Arch Otolaryngol Head Neck Surg. 2006;132(6):579-587.
4. Babu KS, Salvi SS. Aspirin and asthma. Chest. 2000;118(5):1470- 1476.
5. Mullol J, Fernandez-Morata JC, Roca-Ferrer J, et al. Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. J Allergy Clin Immunol. 2002;109(5):824-830.
6. Bonfield TL, Konstan MW, Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol. 1999;104(1):72-78.
7. Bonfield TL, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs [published correction appears in Am J Respir Crit Care Med. 1996;154(4, pt 1):following 1217]. Am J Respir Crit Care Med. 1995;152(6, pt 1):2111-2118.
8. Sobol SE, Christodoulopoulos P, Manoukian JJ, et al. Cytokine profile of chronic sinusitis in patients with cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2002;128(11):1295-1298.
9. Roca-Ferrer J, Pujols L, Gartner S, et al. Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis. Thorax. 2006;61(7):592-596.
10. Rigas B, Korenberg JR, Merrill WW, Levine L. Prostaglandins E2 and E2 alpha are elevated in saliva of cystic fibrosis patients. Am J Gastroenterol. 1989;84(11):1408-1412.
11. Konstan MW, Walenga RW, Hilliard KA, Hilliard JB. Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis. 1993;148(4, pt 1):896-901.
12. Sampson AP, Spencer DA, Green CP, Piper PJ, Price JF. Leukotrienes in the sputum and urine of cystic fibrosis children. Br J Clin Pharmacol. 1990;30(6):861-869.
13. Zakrzewski JT, Barnes NC, Piper PJ, Costello JF. Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay. Br J Clin Pharmacol. 1987;23(1):19-27.
14. Spencer DA, Sampson AP, Green CP, Costello JF. Sputum cysteinyl-leukotriene levels correlate with the severity of pulmonary disease in children with cystic fibrosis. Pediatr Pulmonol. 1992;12(2):90-94.
15. Smith WL, Dewitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol. 1996;62:167-215.
16. Sousa A, Pfister R, Christie PE, et al. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax. 1997;52(11):940-945.
17. Kuitert LM, Newton R, Barnes NC, Adcock IM, Barnes PJ. Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis. Thorax. 1996;51(12):1223-1228.
18. Fernández-Morata JC, Mullol J, Fuentes M, et al. Regulation of cyclooxygenase-1 and -2 expression in human nasal mucosa: effects of cytokines and dexamethasone. Clin Exp Allergy. 2000;30(9):1275-1284.
19. Demoly P, Crampette L, Lebel B, Campbell AM, Mondain M, Bousquet J. Expression of cyclo-oxygenase 1 and 2 proteins in upper respiratory mucosa. Clin Exp Allergy. 1998;28(3):278-283.
20. Demoly P, Jaffuel D, Lequeux N, et al. Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am J Respir Crit Care Med. 1997;155(2):670-675.
21. Redington AE, Meng QH, Springall DR, et al. Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax. 2001;56(5):351-357.
22. Taha R, Olivenstein R, Utsumi T, et al. Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(2, pt 1):636-640.
23. Lee TH, Crea AE, Gant V, et al. Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary disease. Am Rev Respir Dis. 1990;141(6):1453-1458.
24. Peters-Golden M. Cell biology of the 5-lipoxygenase pathway. Am J Respir Crit Care Med. 1998;157(6):S227-S232.
25. Kuhn H, Walther M, Kuban RJ. Mammalian arachidonate 15-lipoxygenases: structure, function, and biologic activity. Prostaglandins Other Lipid Mediat. August 2002;68-69:263-290.
26. De Marzo N, Sloane DL, Dicharry S, Highland E, Sigal E. Cloning and expression of an airway epithelial 12-liopxygenase. Am J Physiol. 1992;262(2, pt 1):L198-L207.
27. Yoshimoto T, Takahashi Y. Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat. August 2002;68-69:245-262.
28. Yoshimura R, Inoue K, Kawahito Y, et al. Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor. Int J Mol Med. 2004;13(1):41-46.
29. Wang H, Li J, Follett PL, et al. 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur J Neurosci. 2004;20(8):2049-2058.
30. Gillis RC, Daley BJ, Enderson BL, Karlstad MD. Role of downstream metabolic processing of proinflammatory fatty acids by 5-lipoxygenase in HL-60 cell apoptosis. J Trauma. 2003;54(1):91-103.
31. Heydeck D, Thomas L, Schnurr K, et al. Interleukin-4 and -13 induce upregulation of the murine macrophage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6. Blood. 1998;92(7):2503-2510.
32. König B, Jaeger KE, Konig W. Induction of inflammatory mediator release (12-hydroxyeicosatetraenoic acid) from human platelets by Pseudomonas aeruginosa. Int Arch Allergy Immunol. 1994;104(1):33-41.